MetalloBio
@metallobioltd.bsky.social
https://www.metallobio.com/about-us/mission-impact
Antimicrobials development company, designing and testing completely new types of antibiotics.
Antimicrobials development company, designing and testing completely new types of antibiotics.
MetalloBio's R&D team has developed a line of new antimicrobial plastics for use in settings where infection control is a high priority consideration. Testing to ISO22196 standards indicates far superior efficacy to currently available products, with an up-to 99.997% reduction in bacterial load.
November 26, 2025 at 10:16 AM
MetalloBio's R&D team has developed a line of new antimicrobial plastics for use in settings where infection control is a high priority consideration. Testing to ISO22196 standards indicates far superior efficacy to currently available products, with an up-to 99.997% reduction in bacterial load.
The sustained efforts of our team have supported a recent slew of granted patents, expanding our intellectual property portfolio.
For the full story:
www.metallobio.com/newsandevent...
For the full story:
www.metallobio.com/newsandevent...
June 5, 2025 at 1:09 PM
The sustained efforts of our team have supported a recent slew of granted patents, expanding our intellectual property portfolio.
For the full story:
www.metallobio.com/newsandevent...
For the full story:
www.metallobio.com/newsandevent...
MetalloBio is pleased to announce the appointment of Dr Eddy Littler as Chairman of the Board. Extensive experience will be important in helping to guide MetalloBio’s growth.
www.metallobio.com/newsandevent...
www.metallobio.com/newsandevent...
March 21, 2025 at 11:10 AM
MetalloBio is pleased to announce the appointment of Dr Eddy Littler as Chairman of the Board. Extensive experience will be important in helping to guide MetalloBio’s growth.
www.metallobio.com/newsandevent...
www.metallobio.com/newsandevent...
Don't invest unless you're prepared to lose all the money you invest.
#crowdfunding #untreatableinfection #investment #innovation #SuperBugs
europe.republic.com/metallobio?i...
#crowdfunding #untreatableinfection #investment #innovation #SuperBugs
europe.republic.com/metallobio?i...
December 18, 2024 at 12:29 PM
Don't invest unless you're prepared to lose all the money you invest.
#crowdfunding #untreatableinfection #investment #innovation #SuperBugs
europe.republic.com/metallobio?i...
#crowdfunding #untreatableinfection #investment #innovation #SuperBugs
europe.republic.com/metallobio?i...
Don't invest unless you're prepared to lose everything you invest.
Complicated infections are predicted to grow substantially in global market value by 2030. Our #R&D is aimed at overcoming #AMR, this impacts every existing antibiotic. It's a significant market.
europe.republic.com/metallobio/s...
Complicated infections are predicted to grow substantially in global market value by 2030. Our #R&D is aimed at overcoming #AMR, this impacts every existing antibiotic. It's a significant market.
europe.republic.com/metallobio/s...
December 16, 2024 at 5:05 PM
Don't invest unless you're prepared to lose everything you invest.
Complicated infections are predicted to grow substantially in global market value by 2030. Our #R&D is aimed at overcoming #AMR, this impacts every existing antibiotic. It's a significant market.
europe.republic.com/metallobio/s...
Complicated infections are predicted to grow substantially in global market value by 2030. Our #R&D is aimed at overcoming #AMR, this impacts every existing antibiotic. It's a significant market.
europe.republic.com/metallobio/s...
Don’t invest unless you’re prepared to lose all the money you invest.
How do we compete with bigger companies and drive value creation? There are five key strengths that we have as a company that builds our value.
#antibioticresistantinfections
europe.republic.com/metallobio/s...
December 15, 2024 at 12:22 PM
Don’t invest unless you’re prepared to lose all the money you invest.
How do we compete with bigger companies and drive value creation? There are five key strengths that we have as a company that builds our value.
#antibioticresistantinfections
europe.republic.com/metallobio/s...
Don't invest unless you're prepared to lose all the money you invest.
In both computer software and #bacterialinfections when an issue arises finding the root cause takes time and work.
We wish to begin treating these issues before they become overwhelming.
europe.republic.com/metallobio/s...
In both computer software and #bacterialinfections when an issue arises finding the root cause takes time and work.
We wish to begin treating these issues before they become overwhelming.
europe.republic.com/metallobio/s...
December 14, 2024 at 11:49 AM
Don't invest unless you're prepared to lose all the money you invest.
In both computer software and #bacterialinfections when an issue arises finding the root cause takes time and work.
We wish to begin treating these issues before they become overwhelming.
europe.republic.com/metallobio/s...
In both computer software and #bacterialinfections when an issue arises finding the root cause takes time and work.
We wish to begin treating these issues before they become overwhelming.
europe.republic.com/metallobio/s...
Don’t invest unless you’re prepared to lose all the money you invest.
MetalloBio has now amassed over 500 investors. Each milestone we hit in funding, pushes our #R&D further which increases the equity value.
Investing helps drive progress forward.
europe.republic.com/metallobio/s...
MetalloBio has now amassed over 500 investors. Each milestone we hit in funding, pushes our #R&D further which increases the equity value.
Investing helps drive progress forward.
europe.republic.com/metallobio/s...
December 12, 2024 at 3:23 PM
Don’t invest unless you’re prepared to lose all the money you invest.
MetalloBio has now amassed over 500 investors. Each milestone we hit in funding, pushes our #R&D further which increases the equity value.
Investing helps drive progress forward.
europe.republic.com/metallobio/s...
MetalloBio has now amassed over 500 investors. Each milestone we hit in funding, pushes our #R&D further which increases the equity value.
Investing helps drive progress forward.
europe.republic.com/metallobio/s...
Don’t invest unless you’re prepared to lose all the money you invest.
What was good for Merck, is good for us. MetalloBio aims to provide solutions for patients and, all being well, profits shall follow. #AMR #HealthForAll
europe.republic.com/metallobio?i...
What was good for Merck, is good for us. MetalloBio aims to provide solutions for patients and, all being well, profits shall follow. #AMR #HealthForAll
europe.republic.com/metallobio?i...
December 6, 2024 at 5:04 PM
Don’t invest unless you’re prepared to lose all the money you invest.
What was good for Merck, is good for us. MetalloBio aims to provide solutions for patients and, all being well, profits shall follow. #AMR #HealthForAll
europe.republic.com/metallobio?i...
What was good for Merck, is good for us. MetalloBio aims to provide solutions for patients and, all being well, profits shall follow. #AMR #HealthForAll
europe.republic.com/metallobio?i...
Don't invest unless you're prepared to lose all the money you invest.
A message from our Executive Chairman and CEO Michael Murray post #GenesisLondon24 conference.
#AntimicrobialResistance #crowdfunding
europe.republic.com/metallobio/s...
A message from our Executive Chairman and CEO Michael Murray post #GenesisLondon24 conference.
#AntimicrobialResistance #crowdfunding
europe.republic.com/metallobio/s...
December 5, 2024 at 3:32 PM
Don't invest unless you're prepared to lose all the money you invest.
A message from our Executive Chairman and CEO Michael Murray post #GenesisLondon24 conference.
#AntimicrobialResistance #crowdfunding
europe.republic.com/metallobio/s...
A message from our Executive Chairman and CEO Michael Murray post #GenesisLondon24 conference.
#AntimicrobialResistance #crowdfunding
europe.republic.com/metallobio/s...
An insidious impact of #AMR is the burden it places on healthcare systems. Simple infections can become serious medical care issues. Our new medications would not only treat patients, but will free up precious/costly healthcare resources, and specialist medical and support staff. #invest #health
December 1, 2024 at 2:25 PM
Without effective antibiotics surgical
procedures and treatment of many diseases
will become almost impossible. What once were
treatable infections could become life
threatening. MetalloBio is working to
meet this global challenge through its
novel paradigm in antibiotics design. #AMR
#Worldhealth
procedures and treatment of many diseases
will become almost impossible. What once were
treatable infections could become life
threatening. MetalloBio is working to
meet this global challenge through its
novel paradigm in antibiotics design. #AMR
#Worldhealth
November 30, 2024 at 4:38 PM
Without effective antibiotics surgical
procedures and treatment of many diseases
will become almost impossible. What once were
treatable infections could become life
threatening. MetalloBio is working to
meet this global challenge through its
novel paradigm in antibiotics design. #AMR
#Worldhealth
procedures and treatment of many diseases
will become almost impossible. What once were
treatable infections could become life
threatening. MetalloBio is working to
meet this global challenge through its
novel paradigm in antibiotics design. #AMR
#Worldhealth
Current antibiotics are all closely related. This means that bacteria are able to quickly evolve resistance to them. MetalloBio compounds rapidly stop bacterial growth, preventing them from developing antibiotic resistance and treating the infection. #AMR #WorldHealth
November 28, 2024 at 1:03 PM
Current antibiotics are all closely related. This means that bacteria are able to quickly evolve resistance to them. MetalloBio compounds rapidly stop bacterial growth, preventing them from developing antibiotic resistance and treating the infection. #AMR #WorldHealth
MetalloBio Webinar- Friday 29 November 2024 at 15:00
Engage directly with Mike (CEO) and Jim (CSO) as they present MetalloBio’s business plan, route to investment return and the company’s science.
Contact edie.john@metallobio.com to reserve a place. Registration closes at 18:00 on Thursday, 28th.
Engage directly with Mike (CEO) and Jim (CSO) as they present MetalloBio’s business plan, route to investment return and the company’s science.
Contact edie.john@metallobio.com to reserve a place. Registration closes at 18:00 on Thursday, 28th.
November 27, 2024 at 12:56 PM
MetalloBio Webinar- Friday 29 November 2024 at 15:00
Engage directly with Mike (CEO) and Jim (CSO) as they present MetalloBio’s business plan, route to investment return and the company’s science.
Contact edie.john@metallobio.com to reserve a place. Registration closes at 18:00 on Thursday, 28th.
Engage directly with Mike (CEO) and Jim (CSO) as they present MetalloBio’s business plan, route to investment return and the company’s science.
Contact edie.john@metallobio.com to reserve a place. Registration closes at 18:00 on Thursday, 28th.
Dr Bernardino de la Serna conducts notably multidisciplinary research, working with an incredible
background of knowledge, his skill in microscopy has captured images of bacteria engaging with Metallic
bio’s antibiotic drug candidates, showing the phenomena that led to rapid death. #WAAW #AMR
background of knowledge, his skill in microscopy has captured images of bacteria engaging with Metallic
bio’s antibiotic drug candidates, showing the phenomena that led to rapid death. #WAAW #AMR
November 25, 2024 at 9:49 AM
These Senior Lecturers based at The University of Sheffield have been working with us, testing
whether our compounds can be incorporated into 3D printing inks. The synergy of their work raises the
possibility that surgical prostheses using MetalloBio compounds can be used in reconstructive surgery.
whether our compounds can be incorporated into 3D printing inks. The synergy of their work raises the
possibility that surgical prostheses using MetalloBio compounds can be used in reconstructive surgery.
November 24, 2024 at 10:05 AM
These Senior Lecturers based at The University of Sheffield have been working with us, testing
whether our compounds can be incorporated into 3D printing inks. The synergy of their work raises the
possibility that surgical prostheses using MetalloBio compounds can be used in reconstructive surgery.
whether our compounds can be incorporated into 3D printing inks. The synergy of their work raises the
possibility that surgical prostheses using MetalloBio compounds can be used in reconstructive surgery.
Dr Adam Varney’s research focuses on antimicrobial drug testing and development. Through his extensive collaborations he tests and discovers mechanisms of action for antimicrobials. Dr Varney’s research has provided MetalloBio with insight into exactly how our compounds kill bacteria. #WAAW #AMR
November 22, 2024 at 3:49 PM
Dr McLean’s work focuses on the microbial colonisation of medical device materials, and evaluating the efficacy of new approaches in its prevention. Her work regarding the characterisation of antimicrobial drugs as part of the development pipeline has been hugely important during our collaboration.
November 22, 2024 at 10:55 AM
Dr McLean’s work focuses on the microbial colonisation of medical device materials, and evaluating the efficacy of new approaches in its prevention. Her work regarding the characterisation of antimicrobial drugs as part of the development pipeline has been hugely important during our collaboration.
Professor Frederik Claeyssens’ work focuses on laser processing of biomaterials. Due to his extensive knowledge and research on this topic his advice to MetalloBio on extremely complex medical device coatings is indispensable whilst we navigate this highly specialised field. #WAAW #AMR
November 21, 2024 at 4:26 PM
Professor Jim A Thomas is one of the co-founders of MetalloBio. Along with his PHD student Kirsty Smitten, Professor Thomas first identified the potential of the antimicrobial compounds that are being developed by MetalloBio. His wealth of knowledge is invaluable in our research. #AMR #WAAW2024
November 21, 2024 at 10:57 AM
